CD274 and breast cancer: PD-L1 expression was associated with a better outcome in earlier stage of ESCC, which has also been observed in NSCLC [34], pulmonary lymphoepithelioma-like carcinoma [35],colorectal cancer [36], breast cancer [14], and melanoma [8].